Chesapeake Wealth Management Sells 57 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Chesapeake Wealth Management lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,596 shares of the healthcare conglomerate’s stock after selling 57 shares during the quarter. Chesapeake Wealth Management’s holdings in UnitedHealth Group were worth $2,325,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in UNH. M&T Bank Corp grew its position in UnitedHealth Group by 13.4% during the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock worth $128,975,000 after acquiring an additional 26,074 shares during the last quarter. Sugarloaf Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 17.6% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after acquiring an additional 1,193 shares in the last quarter. Benjamin Edwards Inc. grew its holdings in UnitedHealth Group by 1,275.3% during the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after purchasing an additional 41,308 shares during the period. Parsifal Capital Management LP bought a new stake in shares of UnitedHealth Group during the third quarter worth approximately $21,165,000. Finally, Signal Advisors Wealth LLC raised its position in UnitedHealth Group by 13.0% during the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after purchasing an additional 1,051 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently issued reports on UNH shares. UBS Group lowered their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday. Morgan Stanley reduced their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Stephens boosted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Finally, Piper Sandler dropped their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Two research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $510.03 on Tuesday. The business’s fifty day simple moving average is $549.37 and its 200-day simple moving average is $563.70. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a market cap of $469.37 billion, a PE ratio of 32.91, a price-to-earnings-growth ratio of 1.39 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter last year, the business posted $5.83 EPS. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.77 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.65%. UnitedHealth Group’s payout ratio is currently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.